Systemic oxytocin treatment modulates alpha 2-adrenoceptors in telencephalic and diencephalic regions of the rat

Brain Res. 2000 Dec 29;887(2):421-5. doi: 10.1016/s0006-8993(00)03017-1.

Abstract

Systemic subchronic oxytocin treatment significantly and substantially increased the B(max) values of the alpha 2 agonist [(3)H]UK14.304 binding sites in the hypothalamus, the amygdala and the paraventricular thalamic nucleus of the rat as shown by quantitative receptor autoradiography. These results suggest that long-term modulation of autonomic and neuroendocrine functions and emotional behaviours elicited by brain oxytocin may involve enhancement of central alpha 2-adrenoceptor function.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic alpha-Agonists / pharmacokinetics
  • Amygdala / physiology
  • Animals
  • Autoradiography
  • Brimonidine Tartrate
  • Diencephalon / drug effects
  • Diencephalon / physiology*
  • Hypothalamus / physiology
  • Male
  • Oxytocin / administration & dosage
  • Oxytocin / pharmacology*
  • Paraventricular Hypothalamic Nucleus / physiology
  • Quinoxalines / pharmacokinetics
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Adrenergic, alpha-2 / drug effects
  • Receptors, Adrenergic, alpha-2 / physiology*
  • Telencephalon / drug effects
  • Telencephalon / physiology*
  • Tritium

Substances

  • Adrenergic alpha-Agonists
  • Quinoxalines
  • Receptors, Adrenergic, alpha-2
  • Tritium
  • Brimonidine Tartrate
  • Oxytocin